BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Johns Hopkins Technology Ventures - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Johns Hopkins Technology Ventures
X-ORIGINAL-URL:https://ventures.jhu.edu
X-WR-CALDESC:Events for Johns Hopkins Technology Ventures
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230511T150000
DTEND;TZID=America/New_York:20230511T190000
DTSTAMP:20230505T160023Z
CREATED:20230505T160023Z
LAST-MODIFIED:20230505T160023Z
UID:33122-1683817200-1683831600@ventures.jhu.edu
SUMMARY:Nucleate Baltimore Final Pitch Showcase
DESCRIPTION:Teams of Activator 2023 will present their innovative technologies and compete to launch their own biotech venture. \n\n\nNucleate\, a student-led non-profit organization\, is dedicated to empowering early-stage life-science startups and emerging biotech leaders. Nucleate Baltimore is delighted to host a pitch showcase for the Activator 2022-23 cohort\, featuring talented teams from major regional biomedical institutions. These trailblazers are presenting groundbreaking work in platform discoveries\, diagnostics\, and therapeutics. \nDon’t miss this engaging afternoon of talks from the next generation of biotech pioneers and their innovative technologies! \nParticipating Teams:\n\nCaleo Biotechnologies: Developing organoid models for high-throughput screening to profile PBD phenotypes.\nCICS Analytics: Utilizing spectroscopic technique for quantitative characterization of therapeutic nanoparticles.\nCurveAssure: Revolutionizing spinal care treatment with non-invasive technology and at-home assessments.\nSclerix Surgical: Introducing a minimally invasive robotic surgery method for delivering biologics to treat retinal degenerative diseases.\n4D Genomics: Implementing low-cell methods to map 3D genome architecture and identify gene therapy targets\, while facilitating in-vivo examination of biological processes.\n\nWe are pleased to announce that Doug Falk\, the CEO of Vita Therapeutics\, will be joining us as the keynote speaker\, discussing his experience as the founder of a Series B biotech company and sharing practical insights on navigating challenges and capitalizing on opportunities in the life science industry. \nOur esteemed judges panel includes representatives from Catalent Pharma Solutions\, Epidarex Capital\, and Catalio Capital Management. \nFood and refreshments will be provided\, and more details regarding parking will be shared soon. \nIf you have any questions or concerns\, please don’t hesitate to contact us at baltimore@nucleate.xyz.
URL:https://ventures.jhu.edu/event/nucleate-baltimore-final-pitch-showcase/
LOCATION:Johns Hopkins Carey Business School\, 100 International Drive\, 24th Floor Conference Center\, Baltimore\, MD\, 21202\, United States
CATEGORIES:Pava Center
END:VEVENT
END:VCALENDAR